Search
Fujifilm’s vendor-agnostic Pathology PACS solution Synapse® Pathology, streamlines case management through proprietary advances in image digitization and solution interoperability to accelerate pathology-report turnaround. The solution’s open, cloud-accessible architecture allows customers to select the instruments, AI tools, and systems required for their own pathology workflows and use cases, such as clinical diagnosis, research, tumor boards, etc. Synapse Pathology enables pathologists to view images and render diagnosis and collaborate instantly from anywhere so they never have to wait for glass again!
In the 7th annual MedTech Breakthrough Awards program, Fujifilm’s Synapse Pathology won the “Best New Technology Oncology Solution” award. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.
Discover intelligent tools that enhance pathology diagnoses, case access, and collaboration.
Designed to seamlessly integrate with Synapse VNA, Synapse Pathology transports pathology images directly into the image archive to enhance the content pool of patient diagnostic evidence. By adding Fujifilm’s Synapse Pathology solution to Synapse VNA, institutions can seamlessly bring pathology into their imaging archives and achieve a unified enterprise-imaging strategy without compromising the workflows and expertise of each individual department.
Fujifilm’s security-first focus offers cloud-hosted delivery models for the full Synapse portfolio, including Synapse Pathology. Our informatics experts work with you to identify the right private, public, or adaptable hybrid cloud delivery model for your enterprise based on your unique challenges, needs, goals, and budget.
Let’s discuss how our Pathology PACS fits into your enterprise imaging strategy.